Home › Meningioma › Texas
Meningioma clinical trials in Texas
4 studies for Meningioma are looking for participants at sites in Texas.
Cities in Texas
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- Memorial Hermann Texas Medical Center, Houston
- UT MD Anderson Cancer Center, Houston
- Memorial Hermann Northeast Hospital, Humble
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT02523014Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
- MD Anderson Cancer Center, Houston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06955169A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- UT MD Anderson Cancer Center, Houston
- UT Health San Antonio Mays Cancer Center, San Antonio
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT07428616Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- UT Southwestern Simmons Cancer Center, Dallas
- Baylor St. Luke's Medical Center | Baylor College of Medicine, Houston
- Houston Methodist Hospital, Houston
- and 2 more
RecruitingObservational study
All ages · All sexes · Updated Jul 22, 2026 · NCT04427384From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.